Caplin Steriles gets INR 218 crore investment from Eight Roads Ventures and F-Prime Capital
NextLevel Health Partners, Inc., Announces Partnership With PatientPing To Improve Member Care And Coordination
Promentis Pharmaceuticals Announces Commencement of Phase 2 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
Menlo Therapeutics’ Serlopitant Granted Breakthrough Therapy Designation by FDA for the Treatment of Pruritus Associated with Prurigo Nodularis
